Skip to main content
. 2012 Aug 30;2012:735342. doi: 10.1155/2012/735342

Figure 1.

Figure 1

Plasma concentrations of interleukin (IL)-17B (part a) and soluble receptor IL-17RB (part b) in Alveolar Echinococcosis (AE) patients and in infection-free controls (CTRL). The patients were grouped according to their state of infection, that is, cured, stable, or progressive (Prog.) Alveolar Echinococcosis. The plasma concentrations are shown as the mean values in pg/mL with the 95% upper and lower confidence interval. The level of significance was adjusted by the Bonferroni-Holm method. Significant differences between the groups are indicated (*P < 0.05, **P < 0.01, and ***P < 0.001).